Showing 1311-1320 of 1616 results for "".
- Dompé Receives Industry Innovation Award for Oxervate Eye Drops for Neurotrophic Keratitishttps://modernod.com/news/dompe-receives-industry-innovation-award-for-oxervate-eye-drops-for-neurotrophic-keratitis/2476372/Dompé Farmaceutici S.p.A and Dompé US Inc. announced that the National Organization for Rare Disorders (NORD) has awarded them the 2019 Industry Innovation Award for Oxervate. The Rare Impact Awards celebrate people, organizations, and innovators making exceptional contributions benefiting rare d
- Gottlieb’s Quick Goodbye Triggers Investor Panic, Biopharma Bewildermenthttps://modernod.com/news/gottliebs-quick-goodbye-triggers-investor-panic-biopharma-bewilderment/2476360/When FDA Commissioner Scott Gottlieb got his job, critics called him a shill and industry types figured they’d gained a friend in the most important drug regulatory agency in the world. It didn’t turn out quite that way. Gottlieb was biopharma-friendly—to the point where the Na
- Bruder Announces Eyeleve Contact Lens Compresshttps://modernod.com/news/bruder-announces-eyeleve-contact-lens-compress/2479603/Bruder Healthcare announces the immediate availability of Eyeleve, a compress clinically proven to increase comfortable contact lens wear time by up to 3 hours daily. The Eyeleve Contact Lens Compress delivers consistent, therapeutic moist heat that alleviates symptoms of meibomian gland d
- ProQR Receives Fast Track Designation from FDA for QR-421a for Usher Syndrome Type 2https://modernod.com/news/proqr-receives-fast-track-designation-from-fda-for-qr-421a-for-usher-syndrome-type-2/2476227/ProQR Therapeutics announced that it received Fast Track designation from the FDA for QR-421a, a first-in-class investigational RNA-based oligonucleotide designed to address the underlying cause of the vision loss associated with Usher syndrome type 2 and non-syndromic retinitis pigmentosa (RP) d
- Notal Vision Engages Wasatch Photonics Bringing AI-Enabled Home-Based OCT Closer to Markethttps://modernod.com/news/notal-vision-engages-wasatch-photonics-bringing-ai-enabled-home-based-oct-closer-to-market/2479605/Notal Vision has announced the achievement of a significant milestone in its plan to develop and commercialize a home-based, patient-operated, spectral-domain optical coherence tomography (SD-OCT) system. The first targeted application of the Notal Home OCT is to monitor wet age-related macular d
- RayOne Aspheric Fully Preloaded IOL Receives FDA Clearancehttps://modernod.com/news/rayone-aspheric-fully-preloaded-iol-receives-fda-clearance/2479618/Rayner announced that the FDA has cleared the RayOne Aspheric fully preloaded IOL injection system for use in the United States. The FDA granted regulatory clearance of the RayOne Aspheric Monofocal (RAO600C), a fully preloaded aberration-neutral IOL covering a power range of +8.0 D to +34
- Carl Zeiss Meditec to Acquire IanTECH, Maker of the miLOOP Device for Cataract Surgeryhttps://modernod.com/news/carl-zeiss-meditec-to-acquire-iantech-maker-of-the-miloop-device-for-cataract-surgery/2479758/Carl Zeiss Meditec announced it has entered into an agreement to acquire IanTECH, the manufacturer of the miLOOP device for cataract surgery. miLOOP is a microinterventional device designed to deliver energy-free endocapsular lens fragmentation independent of phaco energy. Terms of the d
- Rayner’s New UK-Based Manufacturing Facility Receives FDA Approvalhttps://modernod.com/news/rayners-new-uk-based-manufacturing-facility-receives-fda-approval/2479988/The FDA has approved Rayner’s Ridley Innovation Centre, a $40 million purpose-built R&D, training and production facility in Worthing, UK, according to a company news release. This state-of-the-art, dedicated IOL production center has the capability of manufacturing 3 million IOLs each
- Novartis Exits Antibacterial, Antiviral Researchhttps://modernod.com/news/novartis-exits-antibacterial-antiviral-research/2480028/Novartis will close its antibacterial and antiviral research operations in Emeryville, California as part of CEO Vas Narasimhan’s plans to narrow the drugmaker’s R&D focus. Spokesman Ryan McBride said while “there is a commercial market for these medicines…we do not believe
- Nine Members of Congress Honored for Efforts to Preserve Access to Quality Medical Eye Carehttps://modernod.com/news/nine-members-of-congress-honored-for-efforts-to-preserve-access-to-quality-medical-eye-care/2480228/The American Academy of Ophthalmology is honoring nine members of Congress whose legislative efforts are helping to preserve patient access to quality medical and surgical eye care. The Academy is presenting its 2018 Visionary Awards to Sen. Tom Carper, D-Del., Sen. Lisa Murkowski, R-Alaska, Sen.